BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 925138)

  • 1. Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity.
    Harano Y; Ohgaku S; Hidaka H; Haneda K; Kikkawa R; Shigeta Y; Abe H
    J Clin Endocrinol Metab; 1977 Nov; 45(5):1124-7. PubMed ID: 925138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of altered insulin sensitivity in diabetes mellitus assessed by glucose, insulin, and somatostatin infusion.
    Harano Y; Ohgaku S; Kosugi K; Yasuda H; Nakano T; Kobayashi M; Hidaka H; Izumi K; Kashiwagi A; Shigeta Y
    J Clin Endocrinol Metab; 1981 May; 52(5):982-7. PubMed ID: 6112234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of difference in glucose infusion rate on quantification of hepatic glucose production.
    Sheu WH; Hollenbeck CB; Wu MS; Jaspan JB; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1990 May; 70(5):1354-60. PubMed ID: 1970829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indomethacin does not affect endogenous glucose production in type 2 diabetes mellitus.
    Pereira Arias AM; Bisschop PH; Ackermans MT; Endert E; Romijn JA; Sauerwein HP
    Horm Metab Res; 2001 Nov; 33(11):659-63. PubMed ID: 11733868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effects of somatostatin in maturity-onset diabetes.
    Tamborlane WV; Sherwin RS; Hendler R; Felig P
    N Engl J Med; 1977 Jul; 297(4):181-3. PubMed ID: 876274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of insulin resistance during inhibition of endogenous insulin and glucagon secretion by somatostatin in non-obese subjects with impaired glucose tolerance.
    Ratzmann KP; Besch W; Witt S; Schulz B
    Diabetologia; 1981 Sep; 21(3):192-7. PubMed ID: 6117492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes.
    DeFronzo R; Deibert D; Hendler R; Felig P; Soman V
    J Clin Invest; 1979 May; 63(5):939-46. PubMed ID: 376552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of insulin sensitivity in early diabetes. II. Insulin resistance in asymptomatic diabetics.
    Schulz B; Ratzmann KP; Witt S; Anders M; Ehrlich M
    Endokrinologie; 1980 Jul; 76(1):103-11. PubMed ID: 7002536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a 12-hour subcutaneous infusion of somatostatin-14 on blood glucose, insulin and glucagon levels in healthy subjects and insulin dependent diabetics.
    Villaume C; Beck B; Kolopp M; Toussain P; Debry G
    Biomed Pharmacother; 1986; 40(2):61-4. PubMed ID: 2875745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus.
    Wahren J
    Lancet; 1976 Dec; 2(7997):1213-6. PubMed ID: 63040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin sensitivity test using a somatostatin analogue, octreotide (Sandostatin).
    Mimura A; Kageyama S; Maruyama M; Ikeda Y; Isogai Y
    Horm Metab Res; 1994 Apr; 26(4):184-7. PubMed ID: 8082872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibitory effect of somatostatin on growth hormone, insulin and glucagon secretion in diabetes mellitus.
    Ward FR; Leblanc H; Yen SS
    J Clin Endocrinol Metab; 1975 Sep; 41(3):527-32. PubMed ID: 1159060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
    Shilo S; Sotsky M; Shamoon H
    J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ Somatostatin in insulin-dependent diabetics and in pancreatectomized patients (author's transl)].
    Tragl KH; Pointner H; Kinast H; Flegel U; Deutsch E
    Wien Klin Wochenschr; 1976 Sep; 88(16):530-2. PubMed ID: 1033640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin in maturity-onset diabetes.
    Christensen SE; Hansen AP; Lundbaek K
    Diabetes; 1978 Oct; 27(10):1013-9. PubMed ID: 700257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose, insulin and somatostatin infusion for the determination of insulin resistance in liver cirrhosis.
    Greco AV; Rebuzzi AG; Altomonte L; Manna R; Bertoli A; Ghirlanda G
    Horm Metab Res; 1979 Oct; 11(10):547-9. PubMed ID: 521009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diabetogenic action of somatostatin in healthy subjects and in maturity onset diabetics.
    Waldhäusl W; Bratusch-Marrain P; Dudczak R; Deutsch E
    J Clin Endocrinol Metab; 1977 May; 44(5):876-83. PubMed ID: 870515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase by somatostatin of the arginine induced rise in blood glucose in untreated insulin requiring diabetics.
    Waldhäusl W; Bratusch-Marrain P; Nowotny P
    Endokrinologie; 1979; 73(3):323-7. PubMed ID: 499100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating platelet aggregates induced by somatostatin in insulin-dependent diabetic subjects.
    Coppola L; Giugliano D; Tirelli A; Misso L; Sgambato S; D'Onofrio F
    Diabete Metab; 1980 Dec; 6(4):245-9. PubMed ID: 6110570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.